Pharmaceuticals News

San Diego, California--(Newsfile Corp. - December 8, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing drugs targeting the endocannabinoid system, focusing on metabolic conditions and glaucoma, has received a request by OTC Markets Group Inc. ("OTC Markets") to issue this statement about promotional...
Biotechnology, Pharmaceuticals, Cannabis, Health
2023-12-08 5:14 PM EST | Skye Bioscience, Inc.

Vancouver, British Columbia--(Newsfile Corp. - December 8, 2023) - NUNMN's Science Formulation, a prominent online store specializing in NMN (Nicotinamide Mononucleotide) supplements, is excited to announce a strategic partnership with NMN.ca, a distinguished health news outlet. This collaboration is designed to provide the public with the most recent news, research...
Food/Beverages, Healthcare and Hospitals, Pharmaceuticals, Health
2023-12-08 4:37 PM EST | NUNMN

San Diego, California and Johannesburg, South Africa--(Newsfile Corp. - December 5, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing drugs targeting the endocannabinoid system, and Tautomer Bioscience (Pty) Limited ("Tautomer"), a privately-owned biopharmaceutical company focused on addressing unmet medical needs in oncology, pain management and infectious...
Biotechnology, Pharmaceuticals, Cannabis, Health
2023-12-05 7:00 AM EST | Skye Bioscience, Inc.

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) -  BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q3 Performance Update Presentation on Wednesday, December 13, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will...
Biotechnology, Pharmaceuticals, Health
2023-12-01 2:22 PM EST | BioHarvest Sciences Inc.

Toronto, Ontario--(Newsfile Corp. - November 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its financial statements and management discussion and...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Psychedelics
2023-11-30 7:50 AM EST | Braxia Scientific Corp.

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 29, 2023) -  PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities, today announced that Dr. Amy Reichelt, Ph.D., the...
Biotechnology, Pharmaceuticals, Psychedelics
2023-11-29 8:49 AM EST | PurMinds NeuroPharma

INM-089 improves retinal function in in vivo preclinical AMD disease modelEstablishes cannabinol (CBN) analog candidate in a new disease targetVancouver, British Columbia--(Newsfile Corp. - November 29, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare...
Pharmaceuticals
2023-11-29 8:00 AM EST | InMed Pharmaceuticals

Q3 VINIA® revenues of USD 3.24M represent growth of 113% compared to Q3 2022 and 18% increase compared to Q2 2023Year over Year Q3 Gross Profit improved from 18% to 45%Q4 2023 revenue range guidance of USD 4.2M - 4.5MVINIA® total active subscriber count grew by 213% Year over YearVancouver,...
Biotechnology, Pharmaceuticals, Health
2023-11-29 8:00 AM EST | BioHarvest Sciences Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission (the "BCSC") issued an order revoking the Cease Trade Order previously issued by the Commission on October 11,...
Biotechnology, Pharmaceuticals, Health
2023-11-27 1:16 PM EST | Cell MedX Corp

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2023) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a federally regulated manufacturer and distributor of cannabis extracts, announces that it has adopted a shareholder rights plan (the "Rights Plan") and reports that it has...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2023-11-22 7:55 PM EST | Nextleaf Solutions Ltd.

Vancouver, British Columbia and Princeton, New Jersey--(Newsfile Corp. - November 21, 2023) - Xybion Digital Inc. (TSXV: XYBN), a global, low-code SaaS company that enables digital transformation in life sciences and health organizations, the acceleration of new drug development and enables organizations to maintain employee health and safety, today reported...
Healthcare and Hospitals, Pharmaceuticals
2023-11-21 7:16 PM EST | Xybion Digital Inc.

San Diego, California--(Newsfile Corp. - November 21, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing drugs targeting the endocannabinoid system to address diseases including glaucoma and metabolic conditions, will present an overview of its glaucoma program at two ophthalmology-focused conferences. Company executives will introduce SBI-100 Ophthalmic...
Biotechnology, Pharmaceuticals, Cannabis, Health
2023-11-21 7:00 AM EST | Skye Bioscience, Inc.

Vancouver, British Columbia and Princeton, New Jersey--(Newsfile Corp. - November 16, 2023) - Xybion Digital Inc. (TSXV: XYBN) ("Xybion" or the "Company") is pleased to announce the closing of an acquisition (the "Acquisition") of all of the issued and outstanding shares in the capital of Autoscribe Limited ("Autoscribe") pursuant to...
Healthcare and Hospitals, Pharmaceuticals
2023-11-16 12:43 PM EST | Xybion Digital Inc.

Montréal, Quebec--(Newsfile Corp. - November 15, 2023) - Lumiera Health Inc. (TSXV: NHP) announces the results of its annual general and special meeting of shareholders (the "Meeting") held a virtual and by telephone conference, on November 14, 2023.At the Meeting, shareholders elected 6 directors, being Marie Bélanger, Kevin Cole,...
Pharmaceuticals, Health
2023-11-15 4:30 PM EST | Lumiera Health Inc.

Ottawa, Ontario--(Newsfile Corp. - 15 novembre 2023) -  L'Institut canadien des actuaires (ICA) soutient l'objectif du gouvernement fédéral de veiller à ce que tous les gens du Canada aient accès à des médicaments sur ordonnance à des prix abordables. Toutefois, l'ICA estime que cet objectif peut être atteint plus efficacement...
Healthcare and Hospitals, Pharmaceuticals, Health
2023-11-15 2:21 PM EST | Canadian Institute of Actuaries / FR: Institut canadien des actuaires

Ottawa, Ontario--(Newsfile Corp. - November 15, 2023) - The Canadian Institute of Actuaries (CIA) supports the federal government's objective to ensure that all Canadians have access to affordable prescription drugs. However, the CIA believes this can be accomplished more effectively and implemented more quickly by enhancing elements of existing public...
Healthcare and Hospitals, Pharmaceuticals, Health
2023-11-15 2:21 PM EST | Canadian Institute of Actuaries / FR: Institut canadien des actuaires

Natchitoches, Louisiana--(Newsfile Corp. - November 15, 2023) - LeAnn Boyd, Liviniti CEO, has been named the winner of a Bronze Stevie® Award in the Woman of the Year, Healthcare category of the 20th annual Stevie Awards for Women in Business. The awards honor achievements of women executives, entrepreneurs, employees and...
Pharmaceuticals, Health
2023-11-15 8:00 AM EST | Liviniti

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today reports financial results for the first quarter of the fiscal year 2024 which ended September 30,...
Pharmaceuticals
2023-11-14 8:04 AM EST | InMed Pharmaceuticals

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) ("Defence" or the "Company"), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it has successfully submitted on November 9, 2023...
Biotechnology, Pharmaceuticals, Health
2023-11-14 3:15 AM EST | Defence Therapeutics Inc.